tirzepatide hormone 101: Uses, Benefits, Side Effects, and Comparison to Semaglutide Tirzepatide is a New Medication

SURMOUNT-5 trial: 5.9% mean weight loss Glapp users: 7.5% mean weight loss Relative improvement: +27.1% Key insight: Over the first 12 weeks, digitally engaged semaglutide users achieved approximately 2530% greater weight reduction compared to clinical trial participants receiving identical pharmacotherapy

shorter-plan rates are higher

I talked to some Danish folks in research for this episode, and thank you very much

What would it feel like

JACC Heart Fail 8(8):605617 Mehra MR et al (2016) The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update

Yi, M., Niu, M., Xu, L., Luo, S